Search research articles
Contact Us
Filters
Showing results (321-330 of 355) with videos related to
Page
of 36
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2024
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11
Vered Stearns, Opeyemi A Jegede, Victor T-S Chang, et al.
Cancer
|
December 10, 2021
A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152)
Angela R Bradbury, Ju-Whei Lee, Jill Bennett Gaieski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2024
ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer
Bryan P Schneider, Fengmin Zhao, Tarah J Ballinger, et al.
Breast Cancer Research and Treatment
|
July 5, 2024
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)
Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, et al.
Research Square
|
May 15, 2024
A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)
Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 23, 2010
Distress management
Jimmie C Holland, Barbara Andersen, William S Breitbart, et al.
Radiology
|
August 3, 2021
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)
Shinn-Huey S Chou, Justin Romanoff, Constance D Lehman, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 20, 2026
Cluster Randomized Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191
Bonnie Ky, Tao Liu, Kenneth B Margulies, et al.
Radiology
|
September 20, 2021
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)
Shinn-Huey S Chou, Justin Romanoff, Constance D Lehman, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
December 19, 2024
Exploring Gender Differences in Receipt of the 5As for Smoking Cessation for Recently-Diagnosed Cancer Patients (ECOG-ACRIN EAQ171CD)
Lucy Finkelstein-Fox, Jo Rean D Sicks, Lynne I Wagner, et al.
Page
of 36
Search research articles
Search
Showing results (321-330 of 355) with videos related to
Sort By:
Page
of 36
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2024
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11
Vered Stearns, Opeyemi A Jegede, Victor T-S Chang, et al.
Cancer
|
December 10, 2021
A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152)
Angela R Bradbury, Ju-Whei Lee, Jill Bennett Gaieski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2024
ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer
Bryan P Schneider, Fengmin Zhao, Tarah J Ballinger, et al.
Breast Cancer Research and Treatment
|
July 5, 2024
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)
Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, et al.
Research Square
|
May 15, 2024
A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)
Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 23, 2010
Distress management
Jimmie C Holland, Barbara Andersen, William S Breitbart, et al.
Radiology
|
August 3, 2021
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)
Shinn-Huey S Chou, Justin Romanoff, Constance D Lehman, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 20, 2026
Cluster Randomized Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191
Bonnie Ky, Tao Liu, Kenneth B Margulies, et al.
Radiology
|
September 20, 2021
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)
Shinn-Huey S Chou, Justin Romanoff, Constance D Lehman, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
December 19, 2024
Exploring Gender Differences in Receipt of the 5As for Smoking Cessation for Recently-Diagnosed Cancer Patients (ECOG-ACRIN EAQ171CD)
Lucy Finkelstein-Fox, Jo Rean D Sicks, Lynne I Wagner, et al.
Page
of 36